ArticleJournal of personalized medicine2021

Regulation of CTLA-4 and PD-L1 Expression in Relapsing-Remitting Multiple Sclerosis Patients after Treatment with Fingolimod, IFNβ-1α, Glatiramer Acetate, and Dimethyl Fumarate Drugs.

Afshin Derakhshani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.